Search DrRajHealth

Monday, November 6, 2017

The FDA just changed how it reviews genetic health risk tests

A favorable “patient-centered” change in policy. The information from these tests are interesting and relevant. I do agree that customers who order these tests appear more engaged in the results and potential health decisions—perhaps it’s a differentiator versus the more passive option of when your doctor orders testing. Had such testing been available 10 years ago when I was started on a statin medication, perhaps I would not have personally suffered a side effect of rhabdomyolysis (a predilection which was disclosed in the genetic testing).
from Rajesh Harrykissoon, MD

No comments:

Post a Comment